Scinai Immunotherapeutics CEO to lead biopharma manufacturing roundtable in Israel.

miércoles, 7 de enero de 2026, 7:04 am ET1 min de lectura
SCNI--

Scinai Immunotherapeutics CEO Amir Reichman will co-lead a roundtable discussion during HealthIL Week 2026 on biopharma manufacturing in Israel. The discussion will focus on capabilities, gaps, and scale in the country's biopharma development and manufacturing ecosystem. The Manufacturers Association of Israel organized the roundtable, which will take place on January 19, 2026, at Expo Tel Aviv.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios